These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 9809590

  • 1. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.
    Takashima A, Honda T, Yasutake K, Michel G, Murayama O, Murayama M, Ishiguro K, Yamaguchi H.
    Neurosci Res; 1998 Aug; 31(4):317-23. PubMed ID: 9809590
    [Abstract] [Full Text] [Related]

  • 2. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
    Imahori K, Uchida T.
    J Biochem; 1997 Feb; 121(2):179-88. PubMed ID: 9089387
    [Abstract] [Full Text] [Related]

  • 3. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
    Takahashi M, Yasutake K, Tomizawa K.
    J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
    [Abstract] [Full Text] [Related]

  • 4. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
    Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo JM, Hanger D, Mulot S, Marquardt B, Stabel S.
    Curr Biol; 1994 Dec 01; 4(12):1077-86. PubMed ID: 7704571
    [Abstract] [Full Text] [Related]

  • 5. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
    Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP.
    Acta Neuropathol; 2002 Feb 01; 103(2):91-9. PubMed ID: 11810173
    [Abstract] [Full Text] [Related]

  • 6. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta.
    Isagawa T, Mukai H, Oishi K, Taniguchi T, Hasegawa H, Kawamata T, Tanaka C, Ono Y.
    Biochem Biophys Res Commun; 2000 Jun 24; 273(1):209-12. PubMed ID: 10873588
    [Abstract] [Full Text] [Related]

  • 7. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain.
    Hoshi M, Takashima A, Noguchi K, Murayama M, Sato M, Kondo S, Saitoh Y, Ishiguro K, Hoshino T, Imahori K.
    Proc Natl Acad Sci U S A; 1996 Apr 02; 93(7):2719-23. PubMed ID: 8610107
    [Abstract] [Full Text] [Related]

  • 8. Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells.
    Michel G, Mercken M, Murayama M, Noguchi K, Ishiguro K, Imahori K, Takashima A.
    Biochim Biophys Acta; 1998 Apr 10; 1380(2):177-82. PubMed ID: 9565682
    [Abstract] [Full Text] [Related]

  • 9. In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3beta in neuronal apoptosis: links to tau phosphorylation.
    Elyaman W, Terro F, Wong NS, Hugon J.
    Eur J Neurosci; 2002 Feb 10; 15(4):651-60. PubMed ID: 11886446
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
    Zhang Z, Zhao R, Qi J, Wen S, Tang Y, Wang D.
    J Neurosci Res; 2011 Mar 10; 89(3):437-47. PubMed ID: 21259330
    [Abstract] [Full Text] [Related]

  • 11. Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures.
    Zheng WH, Bastianetto S, Mennicken F, Ma W, Kar S.
    Neuroscience; 2002 Mar 10; 115(1):201-11. PubMed ID: 12401334
    [Abstract] [Full Text] [Related]

  • 12. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
    Chen S, An FM, Yin L, Liu AR, Yin DK, Yao WB, Gao XD.
    Neuroscience; 2014 Jan 03; 256():137-46. PubMed ID: 24183963
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
    Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH.
    J Neurochem; 2000 Apr 03; 74(4):1587-95. PubMed ID: 10737616
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3beta in N1E-115 neuroblastoma cells.
    Ishii T, Furuoka H, Muroi Y, Nishimura M.
    J Biol Chem; 2003 Jul 18; 278(29):26970-5. PubMed ID: 12714590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.